0 Maoni
0 Shiriki
54 Mitazamo
0 Hakiki
Tafuta
Gundua watu wapya, unda miunganisho mipya na upate marafiki wapya
-
Tafadhali ingia kwenye akaunti ili kupenda, kushiriki na kutoa maoni!
-
Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...0 Maoni 0 Shiriki 56 Mitazamo 0 Hakiki
-
Asia-Pacific Glioblastoma Multiforme Treatment Market Shows Promising Growth Amid Expanding Oncology Research"Executive Summary Asia-Pacific Glioblastoma Multiforme Treatment Market Research: Share and Size Intelligence CAGR Value Data Bridge Market Research analyses that glioblastoma multiforme treatment market will grow at a CAGR of 9.2% during the forecast period of 2022 to 2029. This Asia-Pacific Glioblastoma Multiforme Treatment Market research report is a painstaking...0 Maoni 0 Shiriki 117 Mitazamo 0 Hakiki
-
BRCA1 and BRCA2 Genes Market Expands as Genetic Testing Adoption Increases in Oncology Care"Comprehensive Outlook on Executive Summary Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Genes Market Size and Share CAGR Value Data Bridge Market Research analyses that the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes market, which is USD 5.62 billion in 2022, is expected to reach USD 11.28 billion by 2030, at a CAGR of 9.10% during the forecast period 2023 to...0 Maoni 0 Shiriki 208 Mitazamo 0 Hakiki
-
Cell Cycle Inhibitors Market Driving Oncology Innovation and Targeted Drug DeliveryExecutive Summary Cell Cycle Inhibitors Market : CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. The market insights gained through this Cell Cycle Inhibitors Market research analysis report facilitates more defined...0 Maoni 0 Shiriki 1KB Mitazamo 0 Hakiki
-
Clinical Laboratory Tests Market: Liquid Biopsy Tests Emerging as High-Growth Oncology Diagnostic SegmentPolaris Market Research has introduced the latest market research report titled Clinical Laboratory Tests Market Size, Share, Trends, & Industry Analysis Report By Type (Blood Count, HGB/HCT, Basic Metabolic Panel), By End Use, and By Region – Market Forecast, 2025–2034 that highlights the major revenue stream for the forecast period. The report contains clear,...0 Maoni 0 Shiriki 70 Mitazamo 0 Hakiki
-
Europe Non-Small Cell Lung Cancer Diagnostics Market Expands with Precision Oncology Investments"Latest Insights on Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Share and Size CAGR Value The Europe non-small cell lung cancer diagnostics market size was valued at USD 850.07 billion in 2025 and is expected to reach USD 2181.09 billion by 2033, at a CAGR of 12.50% during the forecast period The study and analysis...0 Maoni 0 Shiriki 88 Mitazamo 0 Hakiki
-
Europe Non-Small Cell Lung Cancer Diagnostics Market Poised for Growth Amid Advances in Precision Oncology"Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Size and Share Forecast CAGR Value Europe non-small cell lung cancer diagnostics market is expected to reach USD 846.60 million by 2028 from USD 331.31 million in 2020, growing at a steady CAGR of 12.5% in the forecast period of 2021 to 2028. By considering a definite base year and historic year, calculations...0 Maoni 0 Shiriki 242 Mitazamo 0 Hakiki
-
Glioblastoma Multiforme Treatment Market Advances with Breakthrough Therapies and Precision Oncology Developments"Executive Summary Glioblastoma Multiforme Treatment Market Size and Share: Global Industry Snapshot CAGR Value Global glioblastoma multiforme treatment market size was valued at USD 3.09 billion in 2024 and is projected to reach USD 6.44 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032. For the growth of any business, Glioblastoma Multiforme...0 Maoni 0 Shiriki 65 Mitazamo 0 Hakiki
-
Global Altretamine Market to Reach USD 210 Million by 2034, Driven by Rising Ovarian Cancer Cases and Advancements in Oncology TherapiesAccording to new market intelligence from Intel Market Research, the global Altretamine market was valued at USD 120 million in 2024, with projections indicating steady growth to USD 210 million by 2034 at a CAGR of 5.8% during the forecast period (2026-2034). This expansion reflects increasing adoption in oncology treatment protocols, particularly for platinum-resistant ovarian cancer cases,...0 Maoni 0 Shiriki 64 Mitazamo 0 Hakiki
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Maoni 0 Shiriki 135 Mitazamo 0 Hakiki
-
Global Oncology Information System Market to Reach $4.65 Billion by 2033Market Overview The global oncology information system market size was valued at USD 2.43 billion in 2024 and it is projected to reach from USD 2.61 billion in 2025 to USD 4.65 billion by 2033, growing at a CAGR of 7.5% during the forecast period (2025-2033). The global Oncology Information System market continues to evolve rapidly, driven by...0 Maoni 0 Shiriki 623 Mitazamo 0 Hakiki
-
Beyond Resistance: The Evolving 2026 Landscape of Novel Therapeutics for HR+ Advanced Breast Cancer"Executive Summary Post-CDK4/6 Treatment Line Oncology Drugs Market Market Size and Share Across Top Segments The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period By utilizing few steps or a number of...0 Maoni 0 Shiriki 77 Mitazamo 0 Hakiki
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Maoni 0 Shiriki 166 Mitazamo 0 Hakiki
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Maoni 0 Shiriki 732 Mitazamo 0 Hakiki
-
Hemato Oncology Testing Market Size, Precision Medicine Trends, and Strategic Industry Outlook 2032"Latest Insights on Executive Summary Hemato Oncology Testing Market Share and Size During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers This Hemato Oncology Testing Market research report proves to be true in serving the purpose of businesses of making enhanced...0 Maoni 0 Shiriki 401 Mitazamo 0 Hakiki
-
Hemato Oncology Testing Market Size, Share, Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Hemato Oncology Testing Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers Hemato Oncology Testing Market report offers the most appropriate solution for the business requirements in many ways. To be...0 Maoni 0 Shiriki 417 Mitazamo 0 Hakiki
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Maoni 0 Shiriki 568 Mitazamo 0 Hakiki
-
High-Potency Oncology API (HPAPI) Market Analysis, Size, Share, Segments & ForecastExecutive Summary High-Potency Oncology API (HPAPI) Market: Share, Size & Strategic Insights The global High-Potency Oncology API (HPAPI) market size was valued at USD 693 Million in 2025 and is expected to reach USD 1421.90 Million by 2033, at a CAGR of 9.40% during the forecast period. The key topics that have been described in this High-Potency...0 Maoni 0 Shiriki 66 Mitazamo 0 Hakiki
-
High-Potency Oncology API (HPAPI) Market Trends To Watch Growth, Share, SegmentsIn-Depth Study on Executive Summary High-Potency Oncology API (HPAPI) Market Size and Share The global High-Potency Oncology API (HPAPI) market size was valued at USD 693 Million in 2025 and is expected to reach USD 1421.90 Million by 2033, at a CAGR of 9.40% during the forecast period. All statistical and numerical data is interpreted with the use...0 Maoni 0 Shiriki 61 Mitazamo 0 Hakiki
-
Linear Particle Accelerators Market Opportunities: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Linear Particle Accelerators Market Size and Share Global linear particle accelerators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 2,346.51 million in 2020 to USD 3,672.77 million by 2028 growing at a CAGR of 5.76% in the above-mentioned...0 Maoni 0 Shiriki 2KB Mitazamo 0 Hakiki
Matokeo Ya Utafutaji
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
